Latest Serum protein electrophoresis Stories

Study results presented at annual meeting of American Thoracic Society (ATS) PHILADELPHIA, May 22, 2013 /PRNewswire/ -- Grifols, a global healthcare company based in Barcelona, Spain, presented results from a study demonstrating that a higher dose of PROLASTIN(©)-C (Alpha(1)-Proteinase Inhibitor [Human]) increased levels of the alpha(1) protein in patients with alpha(1)antitrypsin (AAT) deficiency to levels that are considered within the normal range for healthy individuals. AAT...

RESEARCH TRIANGLE PARK, N.C., Feb. 5, 2013 /PRNewswire/ -- Grifols, a global healthcare company based in Barcelona, Spain, is commemorating the 25(th) anniversary year of PROLASTIN(®) (alpha(1)-proteinase inhibitor [human]) and the 50th anniversary of the discovery of alpha(1)-antitrypsin deficiency (Alpha1) with a series of events and programs around the world aimed at raising awareness and advancing research into the treatment of alpha1. This rare and life-threatening disease...